Health insurance giant Blue Cross Blue Shield of Texas (NYSE: BLB) will award $4,7 million to support its diabetes coverage in India, the company said on Wednesday.
The government has awarded $1.1 billion in concessional funding to cover health insurance providers to provide diabetes coverage, Blue Cross announced on its website.
The company said it would use the funds to improve the quality of care and improve the patient experience for its diabetes patients.
“This is a critical step to ensure the highest quality of health care for the most vulnerable in our society,” Blue Cross CEO and president Gary Smith said.
“Our diabetes patients in India are the most disadvantaged in our country, but they need the best care and we have worked hard to bring that care to their doorstep,” he added.
Blue Cross said the funds would be used for improved care and better monitoring and diagnosis of diabetes patients, and for the delivery of services for diabetic patients who have managed to improve their diabetes.
In its announcement, Blue CBL said the Indian government’s Diabetes Prevention Program (DPP) has seen an increase in diabetes cases.
In a report released on Tuesday, the United Nations Office on Drugs and Crime (UNODC) said India saw the largest increase in the number of cases of type 2 diabetes among all countries studied, with an average of over 15,000 cases a month.
The study also said that the number is on track to rise to 18 million by 2019.